Skip to content

Postoperative Benefits of Intraoperative Nociception Level (NOL) Titration - Pilot

Postoperative Benefits of Intraoperative NOL Titration - Pilot

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04305015
Enrollment
26
Registered
2020-03-12
Start date
2020-11-09
Completion date
2020-12-30
Last updated
2021-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nociceptive Pain

Keywords

NOL, Nociception

Brief summary

Previous work has shown that NOL (Medasense, Ramat Gan, Israel) accurately quantifies nociception during general anesthesia. Presumably, titrating opioids to NOL will therefore provide individual guidance so that patients will be given about the right amount. Patient given the right amount will presumably awaken quickly when anesthesia is done, and have good initial pain control in the post anesthesia care unit (PACU). To the extent that NOL titration facilitates optimal opioid dosing, patients are likely to have better PACU experiences - which would be an important outcome that clinicians and regulators are likely to take seriously.

Interventions

DEVICENOL Guided Analgesia

NOL values exceeding 25 will typically be treated with boluses of fentanyl 50 µg at roughly 5-minute intervals. The target will be maintained until surgery ends

Clinical judgement will be according to their standard practice and may include interpretation of blood pressure, heart rate, diaphoresis, tearing, and pupil size. Boluses of fentanyl 50 µg can be given per clinical judgement

Sponsors

Medasense Biometrics Ltd
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Anesthesia clinicians cannot be blinded since they will need to titrate opioid administration to NOL. However, all postoperative care and evaluations will be fully blinded to randomization, thus preventing measurement bias

Intervention model description

NOL-Guided analgesia vs. Routine Management

Eligibility

Sex/Gender
ALL
Age
21 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Adults having major non-cardiac surgery expected to last ≥2 hours; 2. American Society of Anesthesiologists physical status 1-3; 3. Age 21-85 years old; 4. Planned endotracheal intubation

Exclusion criteria

1. Planned neuraxial or regional block; 2. Local anesthetic infiltration at surgical field; 3. Clinician preference for an opioid other than, or in addition to, fentanyl; 4. Non-sinus heart rhythm; 5. Neurologic condition that, in the opinion of the investigators, may preclude accurate assessment of postoperative pain and nausea; 6. Lack of English language fluency; 7. Routine user of psychoactive drugs other than opioids; 8. Contraindication to sevoflurane, fentanyl, morphine, or ondansetron. 9. Intracranial surgery 10. BMI \> 40

Design outcomes

Primary

MeasureTime frameDescription
PACU pain score60 minutes during recoveryAverage pain scores (0-10 verbal response scale) at 10-minute intervals during the initial 60 minutes of recovery are more often between 1 and 3 or significantly lower with NOL-guided fentanyl than with routine care

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026